神経再生の世界市場予測(~2024年)

調査会社Market Research Future社が発行したリサーチレポート(データ管理コード:MRF20MY082)
◆英語タイトル:Global Nerve Regeneration Market Research Report Forecast to 2024
◆発行会社/調査会社:Market Research Future
◆商品コード:MRF20MY082
◆発行日:2019年10月
◆調査対象地域:グローバル
◆産業分野:医療
◆ページ数:190
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single User(印刷不可、Online Access)USD4,450 ⇒換算¥507,300見積依頼/購入/質問フォーム
Enterprisewide Price(印刷可)USD6,250 ⇒換算¥712,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Market Research Future社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[神経再生の世界市場予測(~2024年)]についてメールでお問い合わせはこちら
本調査レポートでは、神経再生の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、調査手法、市場動向、市場要因の分析、製品別(神経刺激&神経調節デバイス、内部神経刺激デバイス、外部神経刺激デバイス)分析、用途別(神経刺激&神経調節手術、神経直接修復/神経閉鎖、神経移植、幹細胞療法)分析、エンドユーザー別(病院&診療所、外来手術センター)分析、地域別分析、競争状況、企業情報などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・市場概要
・調査手法
・市場動向
・市場要因の分析
・神経再生の世界市場:製品別(神経刺激&神経調節デバイス、内部神経刺激デバイス、外部神経刺激デバイス)
・神経再生の世界市場:用途別(神経刺激&神経調節手術、神経直接修復/神経閉鎖、神経移植、幹細胞療法)
・神経再生の世界市場:エンドユーザー別(病院&診療所、外来手術センター)
・神経再生の世界市場:地域別
・競争状況
・企業情報
*** レポート概要(サマリー)***

Global Nerve Regeneration Market Research Report: Information by Product, (Neurostimulation & Neuromodulation Devices and Biomaterials), by Application, (Neurostimulation and Neuromodulation Surgeries, Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy and others), by End User (Hospitals & Clinics, Ambulatory Surgery Centers and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2024

[Market analysis]
Rising neurological disorders, increasing geriatric population susceptible to neurological diseases, and technological improvements in the field of nerve regeneration are supposed to enhance the market growth. However, high cost and stringent regulatory framework are projected to restrain the market growth during the forecast period. Nerve regeneration products are used to restore damaged nerves to their normal function, and this procedure is mostly used to treat peripheral nerve injuries. In June 2018, NeuroPace launched a Next Generation RNS System, the world’s only brain-computer interface for the treatment of refractory epilepsy. Nerve injuries are ordinary in the upper (hand and arm) and lower (leg) extremities. Nerve damage can be caused either due to blunt trauma (such as an impact from a fall or from traction injuries from motor vehicle accidents) or sharp trauma (such as from a direct cut from a knife). Surgical nerve repair involves the exploration of the injured nerve and removal of injured tissue from the nerve endings. The Global Nerve Regeneration Market is expected to enroll a CAGR of 11.34% to reach USD 12695.25 million by 2024. The most pressing question in building nerve conduits includes the development of tissue-contrived nerve implants that surpass the execution of autografts; the primary question involved is the sizeable gap between the ends of the nerve. The focus markets are from Pharmaceutical manufacturers, Healthcare providers, Research institutes and academic centers, Government associations, Market research and consulting. This market is witnessing a high growth due to factors such as rising neurological disorders, increasing geriatric populace susceptible to nerve-related diseases, and technological advancements. Moreover, the high cost of products and stringent regulatory framework are expected to hinder the market growth

[Market segmentation]
The Global nerve regeneration market has been segmented into product, application, end user and region. The rising neurological disorders have essentially driven the global nerve regeneration market. For instance, as per the statistics of World Health Organizations (WHO) in 2017, around 50 million people all over the world were affected by epilepsy. Various other factors, such as increasing geriatric population affected by neurological disorders and technological advancements, are also propelling the growth of the market. Neurostimulation and neuromodulation machines held a share of 4,764.96 USD million in 2018. It is estimated that around 250,000 peripheral nerve damages occur yearly in the US alone, which accounts for roughly 42- 43% of the global peripheral nerve injuries. Corresponding to a recent study, around 86-87% of peripheral nerve injuries are caused due to trauma, while the rest are caused due to tumor- and non-tumor-related surgical procedures. Surgical deception or transection during tissue removal can also cause nerve damage. Internal neurostimulation devices has been further bifurcated into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve encouragement, and gastric electrical stimulation. External neurostimulation devices has been further than segmented into transcutaneous electrical nerve stimulation, transcranial magnetic stimulation. Biomaterials has also been categorized as nerve conduits, nerve protectors, nerve wraps, and nerve connectors. Based on application, the market has been categorized as neurostimulation and neuromodulation surgeries, direct nerve repair/neurorrhaphy, nerve grafting, stem cell therapy, and others. Neurostimulation and neuromodulation surgeries have been bifurcated into internal neurostimulation and neuromodulation surgeries, external neurostimulation as well as neuromodulation surgeries. Nerve grafting has been further classified as autografts, allografts, and xenografts. Based on end user, the market has been separated into end user, hospices & clinics, ambulatory surgery centers, and others. Based on product, the market has been segregated into neurostimulation & neuromodulation devices and biomaterials. Based on neurostimulation and neuromodulation tools, the market has been split up into internal neurostimulation devices and external neurostimulation mechanisms.

[Regional analysis]
Geographically, the Global nerve regeneration market is split in regions like North & Latin America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. Europe nerve regeneration market showed considerable growth in the market due to an increase in the healthcare spending by these nations, wide adoption of nerve regeneration methods due to their efficacy to reduce pain and increasing cases of cancer. For the therapy of neurological disorders, the fondness for drug therapies is elevated among patients. This is because there is limited understanding among patients about the accessibility of alternative surgical treatments that make use of nerve repair and rejuvenation devices. Furthermore, surgeons in several countries have limited understanding about the various biomaterials. Asia-Pacific is estimated to be the fastest-growing region in the global nerve regeneration market due to the increasing awareness of neurological disorders and their risk factors and rising incidence of osteoporosis, cancer, and neurological disorders. Japan held a market share of around 25.78% in the Asia-Pacific nerve regeneration market in 2018. The global nerve regeneration market, based on region, has been for four regions, namely the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas accounted for the largest market share in 2018 owing to the attendance of key market players; strategic attainments by major players for ornamental product portfolio; cumulative cases of chronic pain, obesity, and compulsion; and obtainability of technically advanced devices for the analysis and treatment of nerve illnesses.

[Major players]
The proposed spectators in the Global nerve regeneration market are manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global nerve regeneration market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global nerve regeneration market are companies like Integra LifeSciences, Boston Scientific Corporation, LivaNova PLC, Axogen Corporation, Stryker Corporation, Nuvectra Corporation, NeuroPace, Polyganics, Medtronic an Abbott.

*** レポート目次(コンテンツ)***

Table of Contents:

1 Market Introduction
1.1 Definition
1.2 Scope of the Study
1.3 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
2.4 Market Size Estimation
2.5 Forecast Model
3 Market Dynamics
3.1 Introduction
3.2 Drivers
3.2.1 Rising neurological disorders
3.2.2 Increasing geriatric population
3.2.3 Technological advancements
3.3 Restraints
3.3.1 Stringent regulatory framework
3.3.2 High cost
3.4 Opportunity
3.4.1 Entering developing economies
4 Market Factor Analysis
4.1 Value Chain Analysis
4.1.1 Research and Development
4.1.2 Manufacturing
4.1.3 Distribution & Sales
4.1.4 Post-Sales Monitoring
4.2 Porter’s Five Forces Model
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Suppliers
4.2.3 Bargaining Power of Buyers
4.2.4 Threat of Substitutes
4.2.5 Intensity of Rivalry
4.4 Pricing Analysis
5 Global Nerve Regeneration Market, by Product
5.1 Introduction
5.2 Neurostimulation and Neuromodulation Devices
5.2.1 Internal Neurostimulation Devices
5.2.2 External Neurostimulation Devices
5.3 Biomaterials
6 Global Nerve Regeneration Market, by Application
6.1 Introduction
6.2 Neurostimulation and neuromodulation surgeries
6.3 Direct Nerve Repair/Neurorrhaphy
6.4 Nerve Grafting
6.5 Stem Cell Therapy
7 Global Nerve Regeneration Market, by End User
7.1 Introduction
7.2 Hospitals and Clinics
7.3 Ambulatory surgery centers
8 Global Nerve Regeneration Market, by Region
8.1 Overview
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Republic of Korea
8.4.5 Australia
8.4.6 Rest of Asia Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
9 Company Landscape
9.1 Company Share Analysis
10 Company Profile
10.1 Boston Scientific Corporation
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products/Services Offered
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.1.6 Key Strategies
10.2 LivaNova PLC
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products/Services Offered
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.2.6 Key Strategies
10.3 Axogen Corporation
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Products/Services Offered
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.3.6 Key Strategies

10.4 Integra LifeSciences
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products/Services Offered
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.4.6 Key Strategies
10.5 Abbott
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products/Services Offered
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.5.6 Key Strategies
10.6 Stryker Corporation
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products/Services Offered
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.6.6 Key Strategies
10.7 Nuvectra Corporation
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products/Services Offered
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.7.6 Key Strategies
10.8 NeuroPace
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products/Services Offered
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.8.6 Key Strategies
10.9 Polyganics
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products/Services Offered
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.9.6 Key Strategies
10.1 Medtronic
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products/Services Offered
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.10.6 Key Strategies
11 Appendix
11.1 References
11.2 Related Reports

List of Tables:

TABLE 1 GLOBAL NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 2 GLOBAL NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 3 GLOBAL NERVE REGENERATION MARKET FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY REGION, 2016–2024 (USD MILLION)
TABLE 4 GLOBAL NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 5 GLOBAL NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 6 GLOBAL NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 7 GLOBAL NERVE REGENERATION MARKET FOR BIOMATERIALS, BY REGION, 2016–2024 (USD MILLION)
TABLE 8 GLOBAL NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 9 GLOBAL NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 10 GLOBAL NERVE REGENERATION MARKET FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY REGION,
2016–2024 (USD MILLION)
TABLE 11 GLOBAL NERVE REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY REGION,
2016–2024 (USD MILLION)
TABLE 12 GLOBAL NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 13 GLOBAL NERVE REGENERATION MARKET FOR NERVE GRAFTING, BY REGION, 2016–2024 (USD MILLION)
TABLE 14 GLOBAL NERVE REGENERATION MARKET FOR STEM CELL THERAPY, BY REGION, 2016–2024 (USD MILLION)
TABLE 15 GLOBAL NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 16 GLOBAL NERVE REGENERATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016–2024 (USD MILLION)
TABLE 17 GLOBAL NERVE REGENERATION MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2016–2024 (USD MILLION)
TABLE 18 GLOBAL NERVE REGENERATION MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 19 AMERICAS: NERVE REGENERATION MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 20 AMERICAS: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 21 AMERICAS: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 22 AMERICAS: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 23 AMERICAS: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 24 AMERICAS: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 25 AMERICAS: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 26 AMERICAS: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 27 AMERICAS: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 28 AMERICAS: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 29 NORTH AMERICA: NERVE REGENERATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 30 NORTH AMERICA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 31 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 32 NORTH AMERICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 33 NORTH AMERICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 34 NORTH AMERICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 35 NORTH AMERICA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 36 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 37 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 38 NORTH AMERICA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 39 US: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 40 US: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 41 US: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 42 US: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 43 US: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 44 US: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 45 US: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 46 US: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 47 US: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 48 CANADA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 49 CANADA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 50 CANADA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 51 CANADA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 52 CANADA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 53 CANADA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 54 CANADA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 55 CANADA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 56 CANADA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 57 SOUTH AMERICA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 58 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 59 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 60 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 61 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 62 SOUTH AMERICA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 63 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 64 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 65 SOUTH AMERICA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 66 EUROPE: NERVE REGENERATION MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 67 EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 68 EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 69 EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 70 EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 71 EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 72 EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 73 EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 74 EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 75 EUROPE: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 76 WESTERN EUROPE: NERVE REGENERATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 77 WESTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 78 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 79 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 80 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 81 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 82 WESTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 83 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 84 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 85 WESTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 86 GERMANY: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 87 GERMANY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 88 GERMANY: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 89 GERMANY: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 90 GERMANY: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 91 GERMANY: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 92 GERMANY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 93 GERMANY: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 94 GERMANY: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 95 FRANCE: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 96 FRANCE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 97 FRANCE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 98 FRANCE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 99 FRANCE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 100 FRANCE: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 101 FRANCE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 102 FRANCE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 103 FRANCE: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 104 ITALY: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 105 ITALY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 106 ITALY: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 107 ITALY: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 108 ITALY: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 109 ITALY: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 110 ITALY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 111 ITALY: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 112 ITALY: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 113 SPAIN: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 114 SPAIN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 115 SPAIN: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 116 SPAIN: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 117 SPAIN: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 118 SPAIN: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 119 SPAIN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 120 SPAIN: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 121 SPAIN: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 122 UK: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 123 UK: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 124 UK: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 125 UK: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 126 UK: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 127 UK: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 128 UK: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 129 UK: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 130 UK: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 131 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 132 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 133 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 134 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 135 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 136 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 137 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION
SURGERIES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 138 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 139 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 140 EASTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 141 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 142 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 143 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 144 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 145 EASTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 146 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 147 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 148 EASTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 149 ASIA-PACIFIC: NERVE REGENERATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 150 ASIA-PACIFIC: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 151 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 152 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 153 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 154 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 155 ASIA-PACIFIC: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 156 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 157 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 158 ASIA-PACIFIC: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 159 CHINA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 160 CHINA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 161 CHINA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 162 CHINA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 163 CHINA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 164 CHINA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 165 CHINA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 166 CHINA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 167 CHINA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 168 JAPAN: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 169 JAPAN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 170 JAPAN: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 171 JAPAN: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 172 JAPAN: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 173 JAPAN: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 174 JAPAN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 175 JAPAN: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 176 JAPAN: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 177 INDIA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 178 INDIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 179 INDIA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 180 INDIA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 181 INDIA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 182 INDIA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 183 INDIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 184 INDIA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 185 INDIA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 186 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 187 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 188 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 189 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 190 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 191 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 192 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 193 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 194 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 195 AUSTRALIA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 196 AUSTRALIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 197 AUSTRALIA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 198 AUSTRALIA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 199 AUSTRALIA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 200 AUSTRALIA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 201 AUSTRALIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 202 AUSTRALIA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 203 AUSTRALIA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 204 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 205 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 206 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 207 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 208 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 209 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 210 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 211 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 212 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION
SURGERIES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 223 MIDDLE EAST: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 224 MIDDLE EAST: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 225 MIDDLE EAST: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 226 MIDDLE EAST: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 227 MIDDLE EAST: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 228 MIDDLE EAST: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 229 MIDDLE EAST: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES,
BY TYPE, 2016–2024 (USD MILLION)
TABLE 230 MIDDLE EAST: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 231 MIDDLE EAST: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 232 AFRICA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 233 AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 234 AFRICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 235 AFRICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION)
TABLE 236 AFRICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION)
TABLE 237 AFRICA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION)
TABLE 238 AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,
2016–2024 (USD MILLION)
TABLE 239 AFRICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION)
TABLE 240 AFRICA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)

*** 掲載企業 ***

Integra LifeSciences, Boston Scientific Corporation, LivaNova PLC, Axogen Corporation, Stryker Corporation, Nuvectra Corporation, NeuroPace, Polyganics, Medtronic an Abbott

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MRF20MY082 )"神経再生の世界市場予測(~2024年)" (英文:Global Nerve Regeneration Market Research Report Forecast to 2024)はMarket Research Future社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。